At the end of June, the Board of Gavi, the Vaccine Alliance, approved their new “5.0” strategy for 2021-2025, with an ambitious set of priorities for this new phase. In this episode of Take as Directed, Nellie Bristol sits down with Amanda Glassman, Executive Vice President and Senior Fellow of the Center for Global Development, and Katherine Bliss, Senior Fellow with the Global Health Policy Center, to discuss these changes and their implications for the broader immunization landscape beyond 2020.
